Search research articles
Contact Us
Filters
Showing results (771-780 of 932) with videos related to
Page
of 94
Sort By:
Journal for Immunotherapy of Cancer
|
March 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0
Rana R McKay, Archana Ajmera, Michael B Atkins, et al.
Cancer Cell
|
November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
David Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Cancer Immunology Research
|
February 14, 2018
Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events
Dylan J Martini, Lana Hamieh, Rana R McKay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2021
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
Sumanta K Pal, Bradley McGregor, Cristina Suárez, et al.
Clinical Genitourinary Cancer
|
November 21, 2022
Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma
Akram M Shayeb, Hannah Dzimitrowicz McManus, Danielle Urman, et al.
Cancer
|
November 20, 2020
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies
Bradley Alexander McGregor, Matthew T Campbell, Wanling Xie, et al.
Iscience
|
December 11, 2020
An <i>In Vitro</i> Whole-Organ Liver Engineering for Testing of Genetic Therapies
Maëlle Lorvellec, Alessandro Filippo Pellegata, Alice Maestri, et al.
The Journal of Infectious Diseases
|
April 30, 2021
Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019
Enrique Bernal, Lourdes Gimeno, María J Alcaraz, et al.
European Urology
|
August 22, 2013
Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy
Rana R McKay, Nils Kroeger, Wanling Xie, et al.
JCO Global Oncology
|
May 29, 2026
Prostate Cancer Treatment Patterns and Inequities Among Racial Groups in Brazil's Public Health System: Insights From a 16-Year Real-World Study
Daniel Herchenhorn, Haonne Abboud, Vinicius Freire, et al.
Page
of 94
Search research articles
Search
Showing results (771-780 of 932) with videos related to
Sort By:
Page
of 94
Journal for Immunotherapy of Cancer
|
March 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0
Rana R McKay, Archana Ajmera, Michael B Atkins, et al.
Cancer Cell
|
November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
David Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
Cancer Immunology Research
|
February 14, 2018
Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events
Dylan J Martini, Lana Hamieh, Rana R McKay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 7, 2021
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study
Sumanta K Pal, Bradley McGregor, Cristina Suárez, et al.
Clinical Genitourinary Cancer
|
November 21, 2022
Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma
Akram M Shayeb, Hannah Dzimitrowicz McManus, Danielle Urman, et al.
Cancer
|
November 20, 2020
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies
Bradley Alexander McGregor, Matthew T Campbell, Wanling Xie, et al.
Iscience
|
December 11, 2020
An <i>In Vitro</i> Whole-Organ Liver Engineering for Testing of Genetic Therapies
Maëlle Lorvellec, Alessandro Filippo Pellegata, Alice Maestri, et al.
The Journal of Infectious Diseases
|
April 30, 2021
Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019
Enrique Bernal, Lourdes Gimeno, María J Alcaraz, et al.
European Urology
|
August 22, 2013
Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy
Rana R McKay, Nils Kroeger, Wanling Xie, et al.
JCO Global Oncology
|
May 29, 2026
Prostate Cancer Treatment Patterns and Inequities Among Racial Groups in Brazil's Public Health System: Insights From a 16-Year Real-World Study
Daniel Herchenhorn, Haonne Abboud, Vinicius Freire, et al.
Page
of 94